HSPA5 and breast carcinoma: Meanwhile, it seems likely that certain inhibitors of the GRP78 expression/activities in breast cancer cells would help to pharmacologically enhance the antitumor immune response and could be combined with immune checkpoint inhibitors to better treat mammary gland malignancies.